GSK signs oncology deal with UK biotech
May 18, 2009Research and Development, Sales and Marketing GSK, Oxford Biotherapeutics
GSK has struck a deal with Oxford BioTherapeutics to develop therapies for primary, metastatic and recurring forms of cancer. The …
Sanofi-Aventis starts work on dengue fever plant
May 15, 2009Manufacturing and Production Sanofi-Aventis
Sanofi-Aventis' vaccine subsidiary Sanofi Pasteur has broken ground on a 350 million euro facility devoted to the producing a vaccine …
Sanofi-Aventis signs deal with Japanese biotech
May 15, 2009Research and Development, Sales and Marketing Sanofi-Aventis
Sanofi-Aventis has signed an early-stage research deal with biotech Kyowa Hakko Kirin, and will receive rights to its preclinical stage …
Kendle trims down as profits slump
May 15, 2009Research and Development Kendle
Contract research organisation Kendle joined many of its peers in reporting a slump in demand for its clinical research services …
Cohn & Wolfe takes on hepatitis C and substance misuse brief
May 15, 2009Medical Communications Cohn&Wolfe
PR agency Cohn & Wolfe is to handle communications for Schering-Plough's substance misuse and hepatitis C portfolio. It will work …
Boehringer signs diabetes and obesity deal
May 14, 2009Research and Development, Sales and Marketing Boehringer
Boehringer Ingelheim has signed a deal with German biopharma firm DeveloGen to research and develop treatments for diabetes and obesity. …
NHS generic drive saves
May 14, 2009Sales and Marketing NHS
The NHS saved £394 million last year by prescribing cheaper generic medicines, according to an academic study. The Department of …
Does it still pay to be a loyal employee?
May 14, 2009Business Services loyalty, recruitment
Few people can expect to have 'a job for life' anymore, where employees could expect to stay with the same …
Kennedy sets out views on NICE’s future
May 14, 2009Research and Development NICE
Two stakeholder workshops which could shape NICE's future direction are to be held next week. Professor Sir Ian Kennedy has …
API market growth driven by biologics
May 13, 2009Manufacturing and Production biologics
The global market for active pharmaceutical ingredients is being transformed as big pharma companies devote more and more resources to …
Dragon James Caan invests in CSO Star
May 13, 2009Business Services Star
Star, a specialist contract sales organisation and healthcare recruiter, has won the backing of Dragon's Den investor James Caan. The …
AstraZeneca buoyed as Brilinta tops Plavix in trial
May 13, 2009Research and Development, Sales and Marketing AZ, Brillinta
AstraZeneca has been lifted by clinical results indicating its antiplatelet drug Brilinta outperformed Sanofi-Aventis/Bristol-Myers Squibb’s Plavix – currently the world’s …
Pharma manufacturing: news in brief
May 12, 2009Manufacturing and Production Genzyme
Pharmafocus presents a round-up of developments in the pharmaceutical manufacturing sector, including new capital investments at Roche, Genzyme and Aeras, …
GSK boosts stake in Aspen
May 12, 2009Sales and Marketing GSK, generics
GlaxoSmithKline has extended its stake in the South African generics company Aspen to a 16% shareholding. In return it will …
Working Life: Nick Rodgers
May 12, 2009Sales and Marketing WL, Working Life, marketing, product manager
How did you find your way into your current role?I started my pharma career at Schering Healthcare as a representative …
UK a step closer to new swine flu vaccine
May 11, 2009Research and Development NHS, h1n1
The first step towards producing a European prototype of a swine flu vaccine has been achieved by the UK's Health …
GSK claims superiority for Cervarix in head-to-head trial
May 11, 2009Research and Development, Sales and Marketing GSK, vaccines
GlaxoSmithKline says a new study shows its cervical cancer vaccine Cervarix induces a higher immune response compared to rival Gardasil. …
Cmed and Tessella join forces on adaptive trials
May 11, 2009Research and Development Cmed, digi
UK contract research organisation Cmed Research has bolstered its ability to carry out adaptive clinical trials on behalf of clients …
Sanofi hikes flu vaccine capacity with new US plant
May 11, 2009Manufacturing and Production Sanofi-Aventis, h1n1
Sanofi-Aventis has been given a green light for a new $150 million flu vaccine manufacturing plant in the US that …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
